Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Liothyronine

Brand: Tertroxin®
NICE TA: 
Indication: Prescribing by secondary or tertiary care specialists for the treatment of acute conditions where thyroid replacement is needed rapidly, for a limited period and/or where a drug with shorter half-life is required
Disease category: Endocrine system
Commissioning responsibility: CCG
PbR excluded: No

Background

Prescribing by secondary or tertiary care specialists for the treatment of acute conditions where thyroid replacement is needed rapidly, for a limited period and/or where a drug with shorter half-life is required — Red

Liothyronine is recommended for prescribing by secondary or tertiary care specialists in the following settings:

preceding ablation therapy with radioactive iodine
for the treatment of coma of myxedema, the management of severe chronic thyroid deficiency and hypothyroid states occurring in the treatment of thyrotoxicosis.*
treatment of thyrotoxicosis as an adjunct to carbimazole to prevent sub-clinical hypothyroidism developing during treatment.*
treating severe and acute hypothyroid states because of its rapid and more potent effect, thyroxine sodium is normally the drug of choice for routine replacement therapy.*
* = licensed indication
Specialist knowledge, intensive monitoring and specific dose adjustments are necessary. Liothyronine must be supplied by the hospital for the duration of the treatment course. Primary care initiation or continuation of treatment is not recommended unless in exceptional circumstances.

This colour classification is in agreement with the recommendations contained within the NHS England and NHS Clinical Commissioners guidance document ‘Items which should not routinely be prescribed in primary care: Guidance for CCGs‘ published in November 2017

Recommendation

LMMG recommendation: Red
Click here to find the definitions for the colour classifications

Reason for decision:  Specialist medicine

Supporting documents:

New Medicine Recommendation - Liothyronine (596.9 KiB)

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red

Red

Red

Red

Red